A 5-year-old, 520 kg, working Quarter Horse gelding was examined in mid-Spring for acute onset of pyrexia, tachycardia, and stiff gait. The referring veterinarian recorded a fever of 39.8 1C (103.81F) and a heart rate of 60 bpm, and the horse appeared reluctant to move forward. A tentative diagnosis of equine granulocytic anaplasmosis (EGA) was made based on the clinical signs and the location of the horse within an area known to be endemic for the disease. The gelding was treated with oxytetracycline (IV) and flunixin meglumine (IV), but there was no improvement in the horse's condition in the 24 hours after treatment. The gelding was referred for further investigation. The horse had moved within northern California and Nevada several times within the preceding months to work cattle. Exercise intolerance had not been recorded, and the gelding had not displayed similar clinical signs before the acute onset of this episode. The horse had not undertaken strenuous exercise in the week before presentation, and no other horses in its environment were affected. The gelding was fed grass and alfalfa hay, with no pasture grazing and no concentrate supplementation.On examination, the gelding was mildly obtunded and moved slowly and deliberately from the trailer. Physical examination revealed tachycardia (68 bpm) and tachypnea (24 bpm). Rectal temperature was within normal limits. No cardiac arrhythmias were ausculted. Moderate episcleral injection and icterus was evident in the oral, conjunctival, and nicitans mucus membranes, and capillary refill time was within normal limits. The gluteal and epaxial musculature were firm, painful, and nondepressible on palpation.A complete blood count (CBC) revealed lymphopenia (934 mL À1 ; reference range 1,600-5,800 mL
À1) and thrombocytopenia (44,000 mL À1 ; reference range 100,000-225,000 mL
À1). Serum biochemical analysis identified azotemia (serum creatinine concentration 3.0 mg/dL; reference range 0.9-2.0 mg/dL) and a serum urea nitrogen (SUN) concentration (64 mg/dL; reference range 12-27 mg/dL), hyperglycemia (217 mg/dL; reference range 50-107 mg/dL), hyperfibrinogenemia (1,000 mg/dL; reference range 100-400 mg/dL), increased serum creatine kinase (CK) activity (101,077 IU/L; reference range 86-285 IU/L), aspartate aminotransferase (AST) (20,705 IU/ L; reference range 168-494 IU/L), sorbitol dehydrogenase (SDH) (10 mg/dL; reference range 0-8 mg/dL) activities, and total bilirubin concentration (3.1 mg/dL; reference range 0.5-2.3 mg/dL). Analysis of the buffy coat identified numerous small smooth blue inclusions within many of the neutrophils. Most of the inclusions had a clear cytoplasmic vacuole around them. These findings were consistent with those observed after treatment of Anaplasma phagocytophilum infection with pyknotic, condensed organisms within the neutrophils. Blood was submitted for polymerase chain reaction (PCR) analysis for A. phagocytophilum, and blood samples were submitted for electron microscopy in an effort to better characterize the cytoplasmic inclusions....